Amgen (AMGN) Revenue (2009 - 2026)
Amgen's Revenue was $10.37 billion in Q3 2026, up 8.5% from $9.56 billion a year earlier and up 3.1% from the prior quarter.
Amgen (AMGN) Revenue (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Amgen's Revenue was $38.9 billion through Sep 30, 2026, up 8.2% year-over-year; for FY2025, it was $36.75 billion, up 10.0% from FY2024.
- Revenue has now increased for six consecutive years, with a five-year compound annual growth rate of 7.6% (FY2020 to FY2025).
- In earlier years, Revenue was $33.42 billion in FY2024 (+18.6%), $28.19 billion in FY2023 (+7.1%), $26.32 billion in FY2022 (+1.3%) and $25.98 billion in FY2021 (+2.2%).
- The Q3 2026 figure marks the highest quarterly Revenue in data going back to Q1 2009.
- Compared with a year earlier, Revenue has increased for 14 straight quarters, with growth averaging 9.3% over the last eight quarters.
- The best year-over-year quarter for Revenue over five years was Q3 2024 (growth of 23.2%); the worst was Q1 2023 (a decline of 2.1%).
- Per Business Quant data, AMGN's Revenue in the three quarters before Q3 2026 was $10.05 billion (Q2 2026), $8.62 billion (Q1 2026) and $9.87 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 15.07 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 3.44 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 10.37 Bn |
| Jun 30, 2026 | 10.05 Bn |
| Mar 31, 2026 | 8.62 Bn |
| Dec 31, 2025 | 9.87 Bn |
| Sep 30, 2025 | 9.56 Bn |
| Jun 30, 2025 | 9.18 Bn |
| Mar 31, 2025 | 8.15 Bn |
| Dec 31, 2024 | 9.09 Bn |
| Sep 30, 2024 | 8.50 Bn |
| Jun 30, 2024 | 8.39 Bn |
| Mar 31, 2024 | 7.45 Bn |
| Dec 31, 2023 | 8.20 Bn |
| Sep 30, 2023 | 6.90 Bn |
| Jun 30, 2023 | 6.99 Bn |
| Mar 31, 2023 | 6.11 Bn |
| Dec 31, 2022 | 6.84 Bn |
| Sep 30, 2022 | 6.65 Bn |
| Jun 30, 2022 | 6.59 Bn |
| Mar 31, 2022 | 6.24 Bn |
| Dec 31, 2021 | 6.85 Bn |
Amgen Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=AMGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();